-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 WnBB86V+qzDM62DnIUhA0zYN+w2QMhnRq0gRxfsxim/6NmqTMajcpFVPbPHcQoKu
 lCGgUebkOmf24Ek/1ZPyKQ==

<SEC-DOCUMENT>0000012208-09-000082.txt : 20091215
<SEC-HEADER>0000012208-09-000082.hdr.sgml : 20091215
<ACCEPTANCE-DATETIME>20091215131909
ACCESSION NUMBER:		0000012208-09-000082
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20091209
ITEM INFORMATION:		Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
FILED AS OF DATE:		20091215
DATE AS OF CHANGE:		20091215

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIO RAD LABORATORIES INC
		CENTRAL INDEX KEY:			0000012208
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				941381833
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-07928
		FILM NUMBER:		091241118

	BUSINESS ADDRESS:	
		STREET 1:		1000 ALFRED NOBEL DR
		CITY:			HERCULES
		STATE:			CA
		ZIP:			94547
		BUSINESS PHONE:		5107247000
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>b8k12152009.htm
<DESCRIPTION>FORM 8-K 12/15/2009
<TEXT>
<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>
<HEAD>
<TITLE>UNITED STATES</TITLE>
<META NAME="author" CONTENT="Tom Brida">
<META NAME="date" CONTENT="12/14/2009">
</HEAD>
<BODY style="font-family:Times New Roman; font-size:10pt; color:#000000">
<DIV style="width:643.2px"><P style="margin:0px"><BR></P>
<P style="margin:0px; padding-top:4px; border-top:1px solid #7F0000"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px" align=center><B>UNITED STATES</B></P>
<P style="margin:0px" align=center><B>SECURITIES AND EXCHANGE COMMISSION</B></P>
<P style="margin:0px" align=center><B>Washington, D.C. 20549</B></P>
<P style="margin:0px">&nbsp;</P>
<P style="margin:0px; font-size:14pt" align=center><B>FORM 8-K</B></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; padding-top:4px; border-top:1px solid #7F0000"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px" align=center><B>CURRENT REPORT</B></P>
<P style="margin:0px; font-size:8pt" align=center><B>Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</B></P>
<P style="margin:0px">&nbsp;</P>
<P style="margin:0px" align=center><B>Date of Report:&nbsp;&nbsp;December 9, 2009</B></P>
<P style="margin:0px; font-size:8pt" align=center><B>(Date of earliest event reported)</B></P>
<P style="margin:0px">&nbsp;</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; padding-top:4px; border-top:1px solid #7F0000"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; font-size:14pt" align=center><B>BIO-RAD LABORATORIES, INC.</B></P>
<P style="margin:0px; font-size:8pt" align=center><B>(Exact name of registrant as specified in its charter)</B></P>
<P style="margin:0px">&nbsp;</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; padding-top:4px; border-top:1px solid #7F0000"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px" align=center><B>Commission File Number: 1-7928</B></P>
<P style="margin:0px; font-size:8pt">&nbsp;</P>
</DIV><TABLE style="font-size:10pt" cellspacing=0><TR height=0 style="font-size:0"><TD width=360></TD><TD width=7.133></TD><TD width=352.8></TD></TR>
<TR><TD width=360><P style="margin:0px; font-size:8pt">&nbsp;</P>
</TD><TD valign=bottom width=7.133><P style="margin:0px; font-size:8pt">&nbsp;</P>
</TD><TD width=352.8><P style="margin:0px; font-size:8pt">&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=360><P style="margin:0px" align=center><B>Delaware</B></P>
</TD><TD valign=bottom width=7.133><P style="margin:0px; font-size:8pt">&nbsp;</P>
</TD><TD valign=top width=352.8><P style="margin:0px" align=center><B>94-1381833</B></P>
</TD></TR>
<TR><TD valign=top width=360><P style="margin:0px; font-size:8pt" align=center><B>(State or other jurisdiction of</B></P>
<P style="margin:0px; font-size:8pt" align=center><B>incorporation or organization)</B></P>
</TD><TD valign=bottom width=7.133><P style="margin:0px; font-size:8pt">&nbsp;</P>
</TD><TD valign=top width=352.8><P style="margin:0px; font-size:8pt" align=center><B>(I.R.S. Employer</B></P>
<P style="margin:0px; font-size:8pt" align=center><B>Identification No.)</B></P>
</TD></TR>
</TABLE>
<DIV style="width:643.2px"><P style="margin:0px"><BR></P>
<P style="margin:0px; font-size:8pt">&nbsp;</P>
<P style="margin:0px" align=center><B>1000 Alfred Nobel Dr.</B></P>
<P style="margin:0px" align=center><B>Hercules, California 94547</B></P>
<P style="margin:0px; font-size:8pt" align=center><B>(Address of principal executive offices, including zip code)</B></P>
<P style="margin:0px; font-size:8pt">&nbsp;</P>
<P style="margin:0px" align=center><B>(510) 724-7000</B></P>
<P style="margin:0px; font-size:8pt" align=center><B>(Registrant&#146;s telephone number, including area code)</B></P>
<P style="margin:0px; font-size:8pt">&nbsp;</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; padding-top:4px; border-top:1px solid #7F0000"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; font-size:8pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>
<P style="margin:0px; font-size:8pt">&nbsp;</P>
<TABLE style="font-size:10pt" cellspacing=0><TR height=0 style="font-size:0"><TD width=28.8></TD><TD width=562.733></TD></TR>
<TR><TD valign=top width=28.8><P style="margin:0px; font-family:Wingdings; font-size:8pt">&#168;</P>
</TD><TD valign=top width=562.733><P style="margin:0px; font-size:8pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px; font-size:8pt">&nbsp;</P>
<TABLE style="font-size:10pt" cellspacing=0><TR height=0 style="font-size:0"><TD width=28.8></TD><TD width=565.6></TD></TR>
<TR><TD valign=top width=28.8><P style="margin:0px; font-family:Wingdings; font-size:8pt">&#168;</P>
</TD><TD valign=top width=565.6><P style="margin:0px; font-size:8pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px; font-size:8pt">&nbsp;</P>
</DIV><TABLE style="font-size:10pt" cellspacing=0><TR height=0 style="font-size:0"><TD width=28.8></TD><TD width=616.267></TD></TR>
<TR><TD valign=top width=28.8><P style="margin:0px; font-family:Wingdings; font-size:8pt">&#168;</P>
</TD><TD valign=top width=616.267><P style="margin:0px; font-size:8pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</P>
</TD></TR>
</TABLE>
<DIV style="width:643.2px"><P style="margin:0px"><BR></P>
<P style="margin:0px; font-size:8pt">&nbsp;</P>
</DIV><TABLE style="font-size:10pt" cellspacing=0><TR height=0 style="font-size:0"><TD width=28.8></TD><TD width=615></TD></TR>
<TR><TD valign=top width=28.8><P style="margin:0px; font-family:Wingdings; font-size:8pt">&#168;</P>
</TD><TD valign=top width=615><P style="margin:0px; font-size:8pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</P>
</TD></TR>
</TABLE>
<DIV style="width:643.2px"><P style="margin:0px"><BR></P>
<P style="margin-top:0px; margin-bottom:13.333px"><BR>
<BR></P>
<P style="margin-top:0px; margin-bottom:13.333px; page-break-before:always"><B>Item 3.01.&nbsp;&nbsp;&nbsp;&nbsp;Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.</B></P>
<P style="margin-top:6.133px; margin-bottom:6.133px; text-indent:48px; font-size:11pt">On December 9, 2009, Bio-Rad Laboratories, Inc. (the &#147;Company&#148;) received official written notice from the New York Stock Exchange (&#147;NYSE&#148;) that, as a result of the previously reported resignation of Mr. Ruediger Naumann-Etienne from the Company&#146;s Board of Directors, the Company is deficient in meeting the requirements of Section 303A.07(a) of the NYSE Listed Company Manual, which requires a listed company to have three independent directors on its audit committee. &nbsp;If the Company is unable to remedy this deficiency by December 16, 2009, it will be deemed noncompliant and a &#147;BC&#148; or &#147;below compliance&#148; indicator will be placed on the Company&#146;s ticker symbol until the Company regains compliance. &nbsp;The Company is currently seeking a replacement for Mr. Naumann-Etienne to serve on the Company&#146;s Board of Directors and Audit Committee and intends to regain compliance 
with the requirements of Section 303A.07(a) of the NYSE Listed Company Manual as soon as practicable. </P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR>
<BR></P>
<P style="margin:0px; page-break-before:always"><BR></P>
<TABLE style="font-size:10pt" cellspacing=0><TR height=0 style="font-size:0"><TD width=62></TD><TD width=22.067></TD><TD width=559.133></TD></TR>
<TR><TD width=62><P>&nbsp;</P></TD><TD width=22.067><P>&nbsp;</P></TD><TD width=559.133><P>&nbsp;</P></TD></TR>
<TR><TD valign=top width=643.2 colspan=3><P style="margin:0px; padding-right:24px; font-size:5pt">&nbsp;</P>
</TD></TR>
</TABLE>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px; padding-right:24px" align=center><B>SIGNATURES</B></P>
<P style="margin:0px; padding-right:24px">&nbsp;</P>
<P style="margin:0px; padding-right:24px">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>
<P style="margin:0px"><BR></P>
<TABLE style="font-size:10pt" cellspacing=0><TR height=0 style="font-size:0"><TD width=60></TD><TD width=162></TD><TD width=84></TD><TD width=1.333></TD><TD width=55.2></TD><TD width=1.333></TD><TD width=10.667></TD><TD width=1.333></TD><TD width=232.467></TD><TD width=12.8></TD><TD width=12></TD></TR>
<TR><TD width=60><P>&nbsp;</P></TD><TD width=162><P>&nbsp;</P></TD><TD valign=top width=84><P>&nbsp;</P></TD><TD width=1.333><P>&nbsp;</P></TD><TD width=67.2 colspan=3><P>&nbsp;</P></TD><TD width=1.333><P>&nbsp;</P></TD><TD width=257.267 colspan=3><P>&nbsp;</P></TD></TR>
<TR><TD valign=top width=60><P style="margin:0px; padding-right:24px">&nbsp;</P>
</TD><TD width=162><P style="margin:0px; padding-right:24px">&nbsp;</P>
</TD><TD valign=top width=84><P>&nbsp;</P></TD><TD valign=top width=1.333><P style="margin:0px; padding-right:24px">&nbsp;</P>
</TD><TD valign=top width=67.2 colspan=3><P style="margin:0px; padding-right:24px">&nbsp;</P>
</TD><TD valign=bottom width=258.6 colspan=4><P style="margin:0px; padding-right:24px">&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=60><P style="margin:0px; padding-right:24px">&nbsp;</P>
</TD><TD width=162><P style="margin:0px; padding-right:24px">&nbsp;</P>
</TD><TD valign=top width=84><P>&nbsp;</P></TD><TD valign=top width=1.333><P style="margin:0px; padding-right:24px">&nbsp;</P>
</TD><TD valign=top width=67.2 colspan=3><P style="margin:0px; padding-right:24px">&nbsp;</P>
</TD><TD valign=bottom width=258.6 colspan=4><P style="margin:0px; padding-right:24px">&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=60><P style="margin:0px; padding-right:24px">&nbsp;</P>
</TD><TD width=162><P style="margin:0px; padding-right:24px">&nbsp;</P>
</TD><TD valign=top width=84><P>&nbsp;</P></TD><TD valign=top width=1.333><P style="margin:0px; padding-right:24px">&nbsp;</P>
</TD><TD valign=top width=325.8 colspan=7><P style="margin:0px; padding-right:24px">BIO-RAD LABORATORIES, INC.</P>
</TD></TR>
<TR><TD valign=top width=60><P style="margin:0px; padding-right:24px">&nbsp;</P>
</TD><TD width=162><P style="margin:0px; padding-right:24px">&nbsp;</P>
</TD><TD valign=top width=84><P>&nbsp;</P></TD><TD valign=top width=1.333><P style="margin:0px; padding-right:24px">&nbsp;</P>
</TD><TD valign=top width=55.2><P style="margin:0px; padding-right:24px">&nbsp;</P>
</TD><TD valign=bottom width=270.6 colspan=6><P style="margin:0px; padding-right:24px">&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=60><P style="margin:0px; padding-right:24px">Date:</P>
</TD><TD style="border-bottom:1px solid #000000" width=162><P style="margin:0px; padding-right:24px">December 15, 2009</P>
</TD><TD valign=top width=84><P>&nbsp;</P></TD><TD valign=top width=1.333><P style="margin:0px; padding-right:24px">&nbsp;</P>
</TD><TD valign=top width=55.2><P style="margin:0px; padding-right:24px">By:</P>
</TD><TD style="border-bottom:1px solid #000000" valign=bottom width=270.6 colspan=6><P style="margin:0px; padding-right:24px">/s/ Christine A. Tsingos</P>
</TD></TR>
<TR><TD valign=top width=60><P style="margin:0px; padding-right:24px">&nbsp;</P>
</TD><TD valign=top width=162><P style="margin:0px; padding-right:24px">&nbsp;</P>
</TD><TD valign=top width=84><P>&nbsp;</P></TD><TD valign=top width=1.333><P style="margin:0px; padding-right:24px">&nbsp;</P>
</TD><TD valign=bottom width=55.2><P style="margin:0px; padding-right:24px">&nbsp;</P>
</TD><TD valign=bottom width=1.333><P style="margin:0px; padding-right:24px">&nbsp;</P>
</TD><TD valign=bottom width=269.267 colspan=5><P style="margin:0px; padding-right:24px">Christine A. Tsingos</P>
</TD></TR>
<TR><TD valign=top width=60><P style="margin:0px; padding-right:24px">&nbsp;</P>
</TD><TD valign=top width=162><P style="margin:0px; padding-right:24px">&nbsp;</P>
</TD><TD valign=top width=84><P>&nbsp;</P></TD><TD valign=top width=1.333><P style="margin:0px; padding-right:24px">&nbsp;</P>
</TD><TD valign=bottom width=55.2><P style="margin:0px; padding-right:24px">&nbsp;</P>
</TD><TD valign=bottom width=1.333><P style="margin:0px; padding-right:24px">&nbsp;</P>
</TD><TD valign=bottom width=269.267 colspan=5><P style="margin:0px; padding-right:24px">Vice President, Chief Financial Officer</P>
</TD></TR>
<TR><TD valign=top width=60><P style="margin:0px; padding-right:24px">&nbsp;</P>
</TD><TD valign=top width=162><P style="margin:0px; padding-right:24px">&nbsp;</P>
</TD><TD valign=top width=84><P>&nbsp;</P></TD><TD valign=top width=1.333><P style="margin:0px; padding-right:24px">&nbsp;</P>
</TD><TD valign=bottom width=55.2><P style="margin:0px; padding-right:24px">&nbsp;</P>
</TD><TD valign=bottom width=1.333><P style="margin:0px; padding-right:24px">&nbsp;</P>
</TD><TD valign=bottom width=269.267 colspan=5><P style="margin:0px; padding-right:24px">&nbsp;</P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><B>&nbsp;</B></P>
<P style="margin:0px">&nbsp;<A NAME="id_11"></A><A NAME="id_12"></A></P>
<P style="margin:0px"><BR>
<BR></P>
</DIV></BODY>
<!-- EDGAR Validation Code: 0E8FF79C -->
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
